Comprehensive Financial Planning Inc. PA purchased a new stake in shares of Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 6,971 shares of the company’s stock, valued at approximately $557,000.
Separately, Flow Traders U.S. LLC bought a new position in Virtus LifeSci Biotech Products ETF in the 2nd quarter worth $431,000.
Virtus LifeSci Biotech Products ETF Stock Down 2.2%
Shares of Virtus LifeSci Biotech Products ETF stock opened at $84.71 on Friday. Virtus LifeSci Biotech Products ETF has a one year low of $57.61 and a one year high of $90.42. The stock’s fifty day moving average is $85.43 and its 200 day moving average is $82.60.
About Virtus LifeSci Biotech Products ETF
The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.
Featured Stories
- Five stocks we like better than Virtus LifeSci Biotech Products ETF
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding BBP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP – Free Report).
Receive News & Ratings for Virtus LifeSci Biotech Products ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Products ETF and related companies with MarketBeat.com's FREE daily email newsletter.
